Guidance for industry: chronic cutaneous ulcer and burn wounds-developing products for treatment.
D000818:Animals; D002056:Burns / Q000188:drug therapy*; D002908:Chronic Disease; D006224:Cricetinae; D003879:Dermatologic Agents / Q000494:pharmacology* / Q000627:therapeutic use; D004195:Disease Models, Animal; D005260:Female; D006168:Guinea Pigs; D006801:Humans; D008297:Male; D051379:Mice; D016032:Randomized Controlled Trials as Topic; D051381:Rats; D012680:Sensitivity and Specificity; D012883:Skin Ulcer / Q000188:drug therapy*; D013552:Swine; D016896:Treatment Outcome; D014481:United States; D014486:United States Food and Drug Administration; D014945:Wound Healing / Q000187:drug effects
D003879:Dermatologic Agents